About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

NCT05508841·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Carlos Roncero, PhD
CONTACT
troncero@research.baycrest.org
Yashna Kochar, H BSc
CONTACT
ykochar@research.baycrest.org

Lead

Baycrest

With

BrightFocus Foundation

Age

50–90

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Mild to Moderate AD
Score between 18 and 25 on the MoCA
Able to do the N-Back task during the initial screening

You may not be if

No history of stroke or TBI
No shunts or metal in the body
No history of significant heart disease, alcoholism and drug use

The record

StatusRecruiting

PhaseNot applicable

Taking part42

StartedSep 2022

UpdatedAug 13, 2024

Conditions

Alzheimer Disease

Where1

Baycrest Health Sciences
Toronto, Ontario, Canada